CDIO
Cardio Diagnostics Holdings, Inc.
$1.99
-0.12 (-5.69%)
At close · Jul 2
Market Cap
$5.89M
Shares
2,959,469
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.99
Open$2.12
Day$1.93–2.13
52W$0.97–7.91
Avg vol 30d56K
Short int15K · 0.5% float · 1.0d
Short vol21%
DataJan 2022–Jul 2026
Filing10-Q · May 15
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Neutral
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−29% below
+
Price vs 50-day avg
+6% above
◦
RSI (14)
50 · neutral
+
MACD trend
positive
−
52-week position
15% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $2 › 200d $3 — 200d above 50d
◦
Institutional flow
0% holders QoQ · +6 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.50% of float · ▼ -22.8% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
16 holders — mid 1-yr range
Fundamentals
Weak
−
Revenue growth
−58% Y/Y
+
EPS growth
+60% Y/Y
−
Free cash flow
$-5.9M
◦
Balance sheet
net cash $0
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−29% below
Bearish
Price vs 50-day avg
+6% above
Bullish
RSI (14)
50 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
15% · near low
Bearish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.50% of float · ▼ -22.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
16 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $1
Now $2 · 15%
52-wk high $8
vs 200-day avg -29%
vs 50-day avg +6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CDIO
this stock
Cardio Diagnostics Holdings, Inc.
|
$5.89M | -26.6% | -57.5% | — | 0.5% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CDIO | -1.5% | -7.4% | -17.1% | -9.1% | -26.6% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -2.9% | -6.2% | -25.1% | -8.9% | -35.8% |